Molecule Information
General Information of the Molecule (ID: Mol01053)
Name |
Probable dual-specificity RNA methyltransferase RlmN (RLMN )
,Paenibacillus sp.
|
||||
---|---|---|---|---|---|
Synonyms |
23S rRNA (adenine(2503)-C(2))-methyltransferase; 23S rRNA m2A2503 methyltransferase; Ribosomal RNA large subunit methyltransferase N; tRNA (adenine(37)-C(2))-methyltransferase; tRNA m2A37 methyltransferase; AK95_17035
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
rlmN
|
||||
Sequence |
MKPFIYDYSLEELQAWAQENGEPAFRGTQIYDWLYVKRVNDFAEMTNLSKEFRTKLEQEF
SFVTLTEITKLESKDGTVKFLFGLHDDHAIETVIMRHNYGNSICVTTQVGCRIGCTFCAS TLGGLKRNLTSGEIVAQVVQAQKILDKTGERVSSIVIMGSGEPFENYEATMKFLRTMIHE KGLNIGQRHITVSTSGIVPNIYKFTEEDTQINLAISIHAPNDKLRSKLMPVNRRFPFDDV IESLRYYQAKTGRRITFEYALIGGVNDQVEHAEELADVIKDMNCFVNLIPVNHVPERKYV RTSRNDIFKFQRALADKGVNVTIRREQGHDIAAACGQLRAKHMELR Click to Show/Hide
|
||||
Function |
Specifically methylates position 2 of adenine 2503 in 23S rRNA and position 2 of adenine 37 in tRNAs.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Clindamycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Bacterial infection | [1] | |||
Resistant Disease | Bacterial infection [ICD-11: 1A00-1C4Z] | |||
Resistant Drug | Clindamycin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Paenibacillus sp. LC231 | 1120679 | ||
Experiment for Molecule Alteration |
Whole genome sequence assay | |||
Experiment for Drug Resistance |
Broth microdilution method assay | |||
Mechanism Description | A clindamycin resistance gene relates to the Rlmk 23S ribosomal RNA methyltransferase COG family.Clindamycin targets the peptidyltransferase centre and inhibits protein synthesis by interfering with transfer RNA binding at the A-site. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.